An oxidative amidation and heterocyclization approach for the synthesis of β-carbolines and dihydroeudistomin Y

  1. 1,2 ,
  2. 1 ,
  3. 1 ,
  4. 1 and
  5. 2
1Technology Development Centre, Custom Pharmaceutical Services, Dr. Reddy’s Laboratories Ltd., Miyapur, Hyderabad – 500049, India
2Department of Chemistry, College of Engineering, JNTUH, Kukatpally, Hyderabad – 500085, India
  1. Corresponding author email
Associate Editor: J. Aubé
Beilstein J. Org. Chem. 2014, 10, 471–480. https://doi.org/10.3762/bjoc.10.45
Received 13 Nov 2013, Accepted 29 Jan 2014, Published 25 Feb 2014
Full Research Paper
cc by logo

Abstract

A novel synthetic methodology has been developed for the synthesis of dihydro-β-carboline derivatives employing oxidative amidation–Bischler–Napieralski reaction conditions using tryptamine and 2,2-dibromo-1-phenylethanone as key starting materials. A number of dihydro-β-carboline derivatives have been synthesized in moderate to good yields using this methodology. Attempts were made towards the conversion of these dihydro-β-carbolines to naturally occurring eudistomin alkaloids.

Introduction

β-Carboline alkaloids [1] are widespread in plants, animals and some are formed naturally in the biological system. Rinehart et al. [2] reported the isolation of β-carboline alkaloids such as eudistomins [3] and several of its analogues from the active Caribbean colonial tunicate Eudistoma olivaceum. β-Carboline alkaloids bearing a substituted phenylacetyl group at C-1 position such as eudistomin T (1) [4], eudistomin R (2a) and eudistomin S (2b) [5] were isolated by Cardellina et al. [6], and these compounds exhibit antimicrobial activity. Xestomanzamine A (3) [5] is a β-carboline alkaloid with an 1-methyl-1H-imidazole-5-acyl group at the C-1 position and was isolated from the Okinawan marine sponge Xestopongia sp. The other β-carboline alkaloids reported in the literature are fascaplysin (4) [7], eudistomin A (5a) [3], harmine (5b) [8-10], harmaline (5c) [11], and tetrahydroharmine (5d). Among these, methoxy substituted β-carboline alkaloids such as 5b, 5c, and 5d are indigenously used as hallucinogenic drugs. Some β-carbolines, notably tryptoline (5e) and pinoline (5f), are produced naturally in the human body. Recently Heonjoong et al. isolated new β-carboline-based metabolites, designated as eudistomins Y1−Y7 (6ag) [12-14] (Figure 1), from the tunicate of the genus Eudistoma and posses a benzoyl group at the C-1 position of the β-carboline structural framework. Eudistomins Y1−Y7 (6a6g) were evaluated for their antibacterial activity. Eudistomin Y6 (6f) exhibits moderate antibacterial activity against the Gram-positive bacteria Staphylococcus epidermis and Bacillus subtilis.

[1860-5397-10-45-1]

Figure 1: Natural products containing the β-carboline skeletal.

Results and Discussion

There are several approaches known in literature for the synthesis of β-carbolines. Most of the syntheses of eudistomin T (1) are generally carried out either from indole or its suitably substituted derivatives. The acylation of 2-(3-indolyl)ethyl isocyanide with phenylacetyl chloride followed by cyclization and aromatization is well documented in the literature for the synthesis of 1-benzoyldihydro-β-carbolines. The cyclization of the adduct, formed by the reaction of tryptamine with appropriately substituted 1,2,3-tricarbonyl compounds or with glyoxylic acid derivatives under Pictet–Spengler conditions is also reported in literature for the syntheses of eudistomin T (1) and eudistomin S (2b). Jenkins and co-workers reported the synthesis of fascaplysin (4) by the reaction of tryptamine with phenylacetyl chloride and carried out the aromatization under photo-oxidation conditions [15,16]. Lindsley and co-workers [17] reported the synthesis of eudistomins Y1−Y7 (6a6g) under microwave conditions [18]. Considering the complexity involved in the synthesis of several of the starting materials used in the preparation of carbolines, especially tricarbonyl compounds, an alternate approach for the synthesis of 3H-β-carboline is sought after. Herein we described our successful efforts towards the synthesis of 1-benzoyldihydro-β-carbolines or dihydroeudistomin. The previously developed synthetic methodologies in our laboratory [19-24] were utilized for the synthesis of eudistomin Y (6) and its analogues

[1860-5397-10-45-i1]

Scheme 1: Retrosynthetic analysis of 6.

The disconnection approach employed in the synthesis of 1-benzoyl-β-carboline is described in Scheme 1. Accordingly eudistomin Y (6) could be obtained by the aromatization of dihydro-β-carboline 12. The dihydro-β-carboline 12 in turn could be synthesized from ketoamide 9 under Lewis acid mediated Bischler–Napieralski reaction. The key intermediate, ketoamide 9 required for the synthesis could easily be accessed from tryptamine (10) and appropriately substituted 2,2-dibromo-1-phenylethanone (11) [25,26] under oxidative amidation conditions.

The oxidative amidation strategy employed in the current synthesis is previously reported from our group by the reaction of a secondary amine with aryl-2,2-dibromo-1-ethanone under aerial oxidation conditions [24]. Later this methodology was successfully employed in the synthesis of isoquinoline alkaloids [27]. The synthesis of eudistomin Y (6) was initiated with the conversion of the respective 2,2-dibromo-1-phenylethanone to the corresponding Schiff base 14 by reaction with tryptamine in presence of NaI. The Schiff base on in situ oxidation with cumene hydroperoxide afforded an unstable oxaziridine derivative 15. Ring opening of the oxaziridine derivative 15 in presence of base afforded ketoiminol 16, which on iminol–amide tautomerism provided the required α-ketoamide 9 (Scheme 2). It was possible to limit the formation of benzamide impurity 17 in the reaction to <15% (Table 1); however, we were unable to avoid the formation of 17 under any of the attempted reaction conditions (Scheme 3).

[1860-5397-10-45-i2]

Scheme 2: Plausible mechanism of the oxidative amidation for 9.

Table 1: Effect of solvent and additive on the ratio of 9 and 17.

  Base Solvent /Additives Reaction time (h) α-Ketoamide 9 (%) Amide 17 (%)
1 TEA DMSO/NaI 6 60 15
2 TEA Sulfolane/NaI 16 52 15
3 TEA DMSO 25 42 25
[1860-5397-10-45-i3]

Scheme 3: Synthesis of α-ketoamide 9.

The α-ketoamide 9 thus obtained by the oxidative amidation methodology was subjected to a Bischler–Napieralski cyclodehydration reaction in presence of POCl3 [27], however under these conditions 2,9-dihydro-β-carboline derivative 7 was obtained as the major product (less than 10% yield) instead of 4-9-dihydro-β-carboline derivative 12 (Scheme 4). Our attempts to improve the yield of 7 under Bischler–Napieralski cyclodehydration reaction conditions using POCl3 as the Lewis acid were proved to be futile. This prompted us to test the efficiency of other Lewis acids in this cyclodehydration reaction. The Bischler–Napieralski cyclodehydration reaction was then carried out with different Lewis acids such as BF3·Et2O, SnCl4, TiCl4 etc., in mutiple solvents under various reaction conditions. The best conversion was obtained when the reaction was conducted in BF3·Et2O in ether at 25–30 °C and the product dihydro-β-carboline 7 was isolated in 55% of yield.

[1860-5397-10-45-i4]

Scheme 4: Synthesis of dihydroeudistomin Y analogues.

The formation of isomeric 2,9-dihydro-β-carboline derivative 7 as the major product in Bischler–Naperalski reaction conditions is explained in Scheme 5. The initially formed spirocyclic compound 18 undergoes intramolecular rearrangement and afforded the dihydrocarboline framework 19, which on aromatization yielded 20. Based on the reaction conditions 8 can be obtained from 20 after aqueous work-up or at higher temperature heating, 20 undergoes a sequential prototropic migration leading to the formation of 2,9-dihydro-β-carboline derivative 7. To the best of our knowledge, this is a novel method for the synthesis of 1-benzoyldihydrocarboline from α-ketoamide 9 [28].

[1860-5397-10-45-i5]

Scheme 5: Plausible mechanism for the formation of 7.

The structure of 2,9-dihydro-β-carboline 7 and 1-hydroxytetrahydro-β-carboline 8 was confirmed by various NMR techniques such as 2D NMR, COSY as well as HSQC (Figure 2). The coupling of the H2 proton with both H1 and H3 protons is clearly evident in the COSY for 7a, whereas the OH proton in 8a shows a high nOe (Scheme 6).

[1860-5397-10-45-i6]

Scheme 6: Rearrangement of 8a into 7a and coupling interactions of 7a.

[1860-5397-10-45-2]

Figure 2: COSY and HSQC of 8a and 7a.

Dihydro-β-carboline 7 was then subjected to an aromatization reaction to obtain eudistomin Y (6). The aromatization reaction was attempted with oxidizing agents such as DDQ and MnO2 as per the reported conditions in literature. The formation of product 6 was confirmed by LCMS analysis of the crude reaction mixture. However under these conditions product 6 was observed in less than 5% and our attempt to isolate the eudistomin Y (6) in pure form was not successful. The oxidation of compound 7 with oxygen, KMnO4, MnO2 and TBHP as well as dehydrogenation with DBU in different solvents at various temperatures also failed and did not yield the required product. Attempted oxidation of compound 7 under microwave irradiation conditions was also not successful. Probably under all aforementioned conditions, formation of the stable enol 21 might have retarded the aromatization during the course of dehydrogenation reaction of dihydro-β-carboline 7.

Utilizing the oxidative amidation Bischler–Napieralski reaction conditions we have synthesized a number of dihydro-β-carbolines (Table 2) in moderate to good yields. The structures of these compounds were confirmed by spectral and analytical methods.

Table 2: Synthesis of dihydro-β-carbolinesa.

  Dibromo-
ethanone 11
α-Ketoamide 9 Yield of 9 (%) 2,9-Dihydro-
eudistomin 7
Yield of 7 and 8 (%) 1-Hydroxy-4,9-tetra-
hydroeudistomin 8
1 [Graphic 1]
11a
[Graphic 2]
9a
60 [Graphic 3]
7a
40 (7a)
15 (8a)
[Graphic 4]
8a
2 [Graphic 5]
11b
[Graphic 6]
9b
57 [Graphic 7]
7b
48 (7b) 8b
not isolated
3 [Graphic 8]
11c
[Graphic 9]
9c
52 [Graphic 10]
7c
38 (7c) 8c
not isolated
4 [Graphic 11]
11d
[Graphic 12]
9d
45 [Graphic 13]
7d
25 (7d)
12 (8d)
[Graphic 14]
8d
5 [Graphic 15]
11e
[Graphic 16]
9e
38 [Graphic 17]
7e
20 (7e) 8e
not isolated
6 [Graphic 18]
11f
[Graphic 19]
9f
55 [Graphic 20]
7f
38 (7f) 8f
not isolated
7 [Graphic 21]
11g
[Graphic 22]
9g
50 7g
not isolated
45 (8g) [Graphic 23]
8g
8 [Graphic 24]
11h
[Graphic 25]
9h
52 [Graphic 26]
7h
46 (7h) 8h
not isolated
9 [Graphic 27]
11i
[Graphic 28]
9i
60 [Graphic 29]
7i
35 (7i)
20 (8i)
[Graphic 30]
8i
10 [Graphic 31]
11j
[Graphic 32]
9j
42 7j
not isolated
42 (8j) [Graphic 33]
8j

aAll products were characterized by 1H NMR, 13C NMR, Mass and IR.

Conclusion

In conclusion, we have developed an oxidative amidation Bischler–Napieralski reaction methodology for the synthesis of dihydroeudistomin Y (7a7i). A number of 1-benzoyl dihydro-β-carboline derivates have been synthesized as a part of these studies. The oxidative amidation Bischler–Napieralski reaction provides a simple and direct method for the synthesis of carbolines, which are otherwise synthesized by multistage reactions utilizing starting materials which are not readily available.

Experimental

General procedure for the synthesis of α-ketoamides (9a9j)

A mixture of 2,2-dibromo-1-phenylethanone (11a, 6.0 g, 21.6 mmol) and sodium iodide (6.48 g, 43.2 mmol) in dimethyl sulfoxide (30.0 mL) at 25–45 °C was stirred for 40–50 minutes. Triethylamine (6.55 g, 64.8 mmol) and tryptamine (10, 3.45 g, 21.6 mmol) were then added to the mixture under a N2 atmosphere and it was stirred for 1–2 h at 25–45 °C. Then cumene hydroperoxide (88% n-hexane solution, 3.73 g, 21.6 mmol) was added to the mixture over a period of five minutes (exothermic reaction), and it was further stirred for another 3–6 h at the same temperature. After completion of the reaction (TLC), ice water was added to the mixture and extracted with DCM (2 × 50 mL). The DCM layer was washed with aq sodium bisulfite solution (50 mL) followed by brine (50 mL) and H2O (2 × 60 mL). The organic layer was dried (anhyd. Na2SO4) and evaporated to dryness under reduced pressure. The obtained crude product was subjected to CC purification and afforded the desired product in moderate to good yields.

N-(2-(1H-Indol-3-yl)ethyl)-2-oxo-2-phenylacetamide (9a): 60% yield; mp 135–136.7 °C; IR (cm–1): 3408, 3386, 2927, 2862, 1663, 1531, 1288, 1248, 1218, 1093, 1080, 1071, 838, 742; 1H NMR (400 MHz, CDCl3) δH 8.32 (d, J = 8 Hz, 2H), 8.05 (s, 1H, NH), 7.63 (dd, J = 8.4, 6.8 Hz, 2H), 7.47 (t, J = 8 Hz, 2H), 7.38 (d, J = 8 Hz, 1H), 7.22 (dd, J = 6.0, 7.2 Hz, 1H), 7.15 (dd, J = 1.2, 6.8 Hz, 1H), 7.12 (dd, J = 2.0, 8.8 Hz, 1H), 7.10 (s, 1H), 3.75 (q, J = 6.8 Hz, 2H), 3.09 (t, J = 6.8 Hz, 2H); 13C NMR (100 MHz, DMSO-d6) δc 190.4, 164.8, 136.1, 134.3, 132.8, 129.6 (2C), 128.7 (2C), 127.1, 122.8, 120.8, 118.2 (2C), 111.2 (2C), 40.7, 24.7; MS m/z (%): 293 (M + 1), 315 (M + 23).

N-(2-(1H-Indol-3-yl)ethyl)-2-oxo-2-(p-tolyl)acetamide (9b): 57% yield; mp 116.8–118.1 °C; IR (cm–1): 3340, 3255, 3093, 2841, 1661, 1644, 1514, 1457, 1310, 1263, 1224, 1169, 1024, 849, 798, 742; 1H NMR (400 MHz, CDCl3) δH 8.24 (d, J = 8 Hz, 2H), 8.06 (s, 1H, NH), 7.64 (d, J = 8 Hz, 1H), 7.39 (d, J = 8 Hz, 1H), 7.21 (t, J = 7.2 Hz, 2H), 7.13 (t, J = 7.2 Hz, 2H), 7.07 (d, J = 2.4 Hz, 1H), 3.73 (d, J = 6.4 Hz, 2H), 3.07 (t, J = 6.8 Hz, 2H), 2.42 (s, 3H): 13C NMR (100 MHz, DMSO-d6) δc 190.1, 165.2, 145.2, 136.2, 132.3, 129.8, 129.4, 127.1, 125.7, 122.8, 120.9 118.3 (2C), 114.2, 111.3 (2C), 55.7, 24.8, 21.4; MS m/z (%): 307.5 (M + 1), 329.5 (M + 23).

N-(2-(1H-Indol-3-yl)ethyl)-2-oxo-2-(4-(trifluoromethyl)phenyl)acetamide (9c): 52% yield; mp 139.8–140.1 °C; IR (cm−1): 3338, 2938, 2842, 1640, 1334, 1224, 1157, 1135, 1075, 935, 842, 794, 747; 1H NMR (400 MHz, CDCl3) δH 8.42 (d, J = 8 Hz, 2H), 8.06 (s, 1H, NH), 7.73 (d, J = 8 Hz, 2H), 7.64 (d, J = 8 Hz, 1H), 7.40 (d, J = 8 Hz, 1H), 7.22 (t, J = 7.2 Hz, 1H), 7.14 (t, J = 7.2 Hz, 2H), 3.75 (d, J = 6.8 Hz, 2H), 3.09 (t, J = 6.8 Hz, 2H); 13C NMR (100 MHz, DMSO-d6) δc 189.0, 163.7, 136.1 (2C), 130.4 (2C), 127.1, 125.6 (2C), 122.8, 120.8 118.2 (2C), 111.2 (2C), 39.2, 24.7; MS m/z (%): 383 (M + 1), 405 (M + 23).

N-(2-(1H-Indol-3-yl)ethyl)-2-(4-fluorophenyl)-2-oxoacetamide (9d): 45% yield; mp 138.5–141.2 °C; IR (cm−1): 3338, 3335, 2923, 2858, 1682, 1651, 1595, 1522, 1352, 1273, 1228, 1152, 850, 798, 742; 1H NMR (400 MHz, CDCl3) δH 8.41 (dd, J = 5.2, 2 Hz, 2H), 8.09 (s, 1H, NH), 7.63 (d, J = 7.6 Hz, 1H), 7.38 (d, J = 8 Hz, 1H), 7.21 (t, J = 7.2 Hz, 1H), 7.14 (t, J = 2 Hz, 1H), 7.13 to 7.11 (m, 1H), 7.10 (t, J = 2 Hz, 1H), 7.06 (d, J = 1.6 Hz, 1H), 3.73 (d, J = 6.4 Hz, 2H), 3.07 (t, J = 6.8 Hz, 2H); 13C NMR (100 MHz, CDCl3) δc 188.6, 164.3, 163.0, 136.1, 132.9, 132.7, 129.6, 127.1, 122.8, 120.9, 116.1, 115.7, 118.2 (2C), 111.2 (2C), 39.2, 24.7; MS m/z (%): 311.5 (M + 1), 333.4 (M + 23).

N-(2-(1H-Indol-3-yl)ethyl)-2-(3-nitrophenyl)-2-oxoacetamide (9e): 38% yield; mp 138.1–139.5 °C; IR (cm−1): 3364, 3331, 3121, 2860, 1662, 1523, 1346, 1263, 1212, 1098, 815, 752, 725; 1H NMR (400 MHz, CDCl3) δH 9.13 (s, 1H), 8.68 (d, J = 7.2 Hz, 1H), 8.46 (d, J = 7.2 Hz, 2H), 8.09 (s, 1H, NH), 7.67 (dd, J = 8 Hz, 1H), 7.40 (d, J = 8 Hz, 1H), 7.25 to 7.10 (m, 3H, ArH), 3.77 (d, J = 6.6 Hz, 2H), 3.10 (t, J = 7 Hz, 2H); 13C NMR (100 MHz, DMSO-d6) δc 187.3, 162.8, 147.7, 136.1, 135.8, 134.1, 130.4, 128.2, 127.2, 124.2, 122.7, 120.8, 118.2, 111.2, 39.2, 24.7; MS m/z (%): 338.5 (M+), 360.5 (M+, 23).

General procedure for the synthesis of dihydroeudistomin (7a7j)

To a stirred solution of N-(2-(1H-indol-3-yl)ethyl)-2-oxo-2-phenylacetamide (9a, 2.0 g, 6.8 mmol) in diethyl ether (20 mL) was added 48% boron trifluoride etherate (10.1 g, 34.2 mmol) in a round-bottom flask under a N2 atmosphere, and the mixture was stirred at 25–30 °C for 2 h. After TLC indication for absence of starting material toluene (20 mL) was added. Then mixture was heated to 55–70 °C and it was maintained under stirring at that temperature for 4–8 h (TLC). The mixture was cooled to 25–30 °C and it was poured into a pre-cooled sat. NaHCO3 solution (160 mL) at 10 °C. The product was then extracted with ethyl acetate (2 × 25 mL) and the organic layer was washed with 10% NaHCO3 solution (25 mL) and dried (anhyd. Na2SO4). The solvent was distilled off under reduced pressure and the crude residue was subjected to column chromatography purification. The product was obtained in good to moderate yields.

(2,9-Dihydro-1H-pyrido[3,4-b]indol-1-yl)(phenyl)methanone (7a): 40% yield; mp 228.5–230.6 °C; 1H NMR (400 MHz, DMSO-d6) δH 11.37 (br s, 1H, NH), 9.68 (d, J = 5.2 Hz, 1H), 7.65 (d, J = 8.0 Hz, 1H), 7.42 (d, J = 7.6 Hz, 1H), 7.26 (t, J = 7.4 Hz, 2H), 7.22 (d, J = 7.2 Hz, 1H), 7.16 (t, J = 7.6 Hz, 1H), 7.08 (t, J =7.2 Hz, 1H), 7.01 (d, J = 7.2 Hz, 2H), 6.34 (d, J = 8.8 Hz, 1H), 5.77 (dd, J = 3.2 & 5.6 Hz, 1H), 5.29 (s, 1H); 13C NMR (100 MHz, DMSO-d6) δc 167.1, 136.4, 136.1, 130.8, 128.5 (2C), 127.2, 126.6 (2C), 125.9, 122.0, 119.6, 118.7, 118.2, 111.6, 109.9, 105.7, 53.2; MS m/z (%): 275.1 (M + 1), 297.2 (M + 23); HRMS (EI) m/z: [M]+ calcd for C18H15N2O, 275.1184; found, 275.1173.

(1-Hydroxy-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)(phenyl)methanone (8a): 15% yield; mp 138.5–141.2 °C; 1H NMR (400 MHz, DMSO-d6) δH 10.93 (s, 1H), 8.52 (t, J = 5.2 Hz, 1H, NH), 7.44 (d, J = 6.8 Hz, 2H), 7.33 to 7.26 (m, 3H, ArH), 7.11 (t, J = 6.0 Hz, 1H), 7.06 (d, J = 5.6 Hz, 2H), 7.00 (t, J = 6.0 Hz, 1H), 6.13 (s, 1H, D2O exchangable proton), 3.10–3.02 (m, 2H), 2.88–2.49 (m, 2H); 13C NMR (100 MHz, DMSO–d6) δc 173.9, 143.9, 135.0, 131.0, 128.3 (2C), 127.8, 127.8, 126.0 (2C), 121.3, 118.5, 117.9, 111.5, 108.4, 75.6 (alkoxy carbon), 38.3, 25.2. HRMS (EI) m/z: [M]+ calcd for C18H17N2O2, 293.1290; found, 293.1333; HRMS of dehydrated 8a (EI) m/z: [M]+ calcd for C18H15N2O, 275.1184; found, 275.1220.

(2,9-Dihydro-1H-pyrido[3,4-b]indol-1-yl)(p-tolyl)methanone (7b): 48% yield; mp 213.2–215.7 °C; IR (cm−1): 3222, 3179, 3043, 2940, 1656, 1625, 1558, 1479, 1335, 1246, 1065, 802, 768, 739; 1H NMR (400 MHz, DMSO-d6) δH 11.36 (br s, 1H, NH), 9.64 (d, J = 4.8 Hz, 1H), 7.64 (d, J = 7.6 Hz, 1H), 7.41 (d, J = 8.0 Hz, 1H), 7.15 (t, J = 7.6 Hz, 1H), 7.10 (d, J = 7.6 Hz, 1H), 7.06 (d, J = 7.6 Hz, 2H), 6.89 (d, J = 8.0 Hz, 2H), 6.32 (d, J = 8.4 Hz, 1H), 5.76 (dd, J = 3.6 & 5.6 Hz, 1H), 5.23 (s, 1H), 2.20 (s, 3H); 13C NMR (100 MHz, CDCl3 + DMSO-d6) δc 166.3, 135.1, 134.9, 131.5, 129.7, 127.5 (2H), 125.4 (2C), 124.6, 120.3, 118.1, 117.1, 116.5, 110.1, 108.5, 104.5, 51.6, 19.5; MS m/z (%): 289.5 (M + 1), 311.5 (M + 23); HRMS (EI) m/z: [M]+ calcd for C19H17N2O, 289.1341; found, 289.1329.

(2,9-Dihydro-1H-pyrido[3,4-b]indol-1-yl)(4-(trifluoromethyl)phenyl)methanone (7c): 38% yield. mp 162–164 °C; IR (cm−1): 3222, 3185, 3042, 2937, 2835, 1657, 1624, 1509, 1456, 1249, 1177, 1055, 1032, 848, 810, 770, 742; 1H NMR (400 MHz, CDCl3) δH 8.10 (s, 1H), 7.69 (d, J = 7.6 Hz, 1H), 7.58 (d, J = 8.0 Hz, 2H), 7.38 (t, J = 8.0 Hz, 2H), 7.29–7.21 (m, 4H), 6.48 (d, J = 8.8 Hz, 1H), 5.94 (dd, J = 3.6 & 5.6 Hz, 1H), 5.19 (s, 1H); 13C NMR (100 MHz, DMSO-d6) δc 166.0, 140.5, 136.3, 129.9, 127.9, 127.6, 127.4 (2C), 125.6 (doublet), 125.3 (2C), 121.9, 119.5, 118.7, 118.1, 111.6, 109.9, 105.7, 52.7; MS m/z (%): 343 (M + 1); HRMS (EI) m/z: [M]+ calcd for C19H14N2OF3, 343.1058; found, 343.1038.

(2,9-dihydro-1H-pyrido[3,4-b]indol-1-yl)(4-fluorophenyl)methanone (7d): 25% yield; mp 230.6–232.2 °C; IR (cm−1): 3351, 3279, 3083, 2895, 2839, 1659, 1605, 1508, 1459, 1304, 1234, 1161, 1072, 956, 837, 747; 1H NMR (400 MHz, CDCl3) δH 8.12 (s, 1H), 7.68 (d, J = 7.6 Hz, 1H), 7.37 (d, J = 7.6 Hz, 1H), 7.27–7.19 (m, 4H, ArH), 7.00 (t, J = 8.8 Hz, 2H), 6.51 (d, J = 8.4 Hz, 1H), 5.94 (dd, J = 3.6 & 4.8 Hz, 1H), 5.08 (s, 1H); 13C NMR (100 MHz, DMSO-d6) δc 166.7, 162.4, 136.3, 132.1, 132.1, 130.6 (doublet), 128.6 (2C), 128.6, 125.7, 121.9, 119.5, 118.7, 118.1, 115.3, 115.1, 111.6, 109.8, 105.6, 52.3; MS m/z (%): 293 (M + 1); HRMS (EI) m/z: [M]+ calcd for C18H14N2OF, 293.1090; found, 293.1073.

(4-Fluorophenyl)(1-hydroxy-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)methanone (8d): 12% yield; mp 185–187 °C; IR (cm−1): 3268, 3178, 3041, 2934, 1658, 1626, 1506, 1471, 1335, 1239, 1225, 1156, 1014, 976, 840, 816, 738; 1H NMR (400 MHz, CDCl3 + DMSO-d6) δH 9.65 (s, 1H), 7.89 (t, J = 6.8 Hz, 1H), 7.47 (t, J = 9.4 Hz, 3H), 7.22–7.08 (m, H, ArH), 6.96 (t, J = 8.8 Hz, 2H), 5.92 (s, 1H), 3.24–3.19 (m, 2H), 2.94 (m, 2H); 13C NMR (100 MHz, DMSO-d6) δc 173.6, 140.3, 135.0, 130.8, 128.2, 128.1, 127.7, 121.4, 118.5, 118.0, 115.3, 114.9, 111.5, 108.5, 75.0, 25.1; MS m/z (%): 293 (M + 1), 315 (M + 23); HRMS (EI) m/z: [M]+ calcd for C18H14N2OF, 293.1090; found, 293.1070.

Supporting Information

Supporting Information File 1: Experimental and analytical data.
Format: PDF Size: 4.8 MB Download

Acknowledgements

The authors would like to thank Dr. Vilas H. Dahanukar, Dr.Reddy’s Laboratories for useful discussions and constant encouragement. We also thank Gajanan S. Botre from the analytical department, Dr. Reddy’s Laboratories, for providing the HRMS data.

References

  1. Cao, R.; Peng, W.; Wang, Z.; Xu, A. Curr. Med. Chem. 2007, 14, 479–500. doi:10.2174/092986707779940998
    Return to citation in text: [1]
  2. Rinehart, K. L., Jr.; Kobayashi, J.; Harbour, G. C.; Hughes, R. G., Jr.; Mizsak, S. A.; Scahill, T. A. J. Am. Chem. Soc. 1984, 106, 1524–1526. doi:10.1021/ja00317a079
    Return to citation in text: [1]
  3. Rinehart, K. L., Jr.; Kobayashi, J.; Harbour, G. C.; Gilmore, J.; Mascal, M.; Holt, T. G.; Shield, L. S.; Lafargue, F. J. Am. Chem. Soc. 1987, 109, 3378–3387. doi:10.1021/ja00245a031
    Return to citation in text: [1] [2]
  4. Rocca, P.; Marsais, F.; Godard, A.; Quéguiner, G.; Adams, L.; Alo, B. Synth. Commun. 1995, 25, 3373–3379. doi:10.1080/00397919508013858
    Return to citation in text: [1]
  5. Molina, P.; Fresneda, P. M.; Garcia-Zafra, S. Tetrahedron Lett. 1996, 37, 9353–9356. doi:10.1016/S0040-4039(97)82962-0
    Return to citation in text: [1] [2]
  6. Kinzer, F. K.; Cardellina, J. H., II. Tetrahedron Lett. 1987, 28, 925–926. doi:10.1016/S0040-4039(00)95875-1
    Return to citation in text: [1]
  7. Mahale, S.; Aubry, C.; Wilson, A. J.; Jenkins, P. R.; Maréchal, J.-D.; Sutcliffe, M. J.; Chaudhuri, B. Bioorg. Med. Chem. Lett. 2006, 16, 4272–4278. doi:10.1016/j.bmcl.2006.05.065
    Return to citation in text: [1]
  8. Callaway, J. C. J. Psychoact. Drugs 2005, 37, 151–155. doi:10.1080/02791072.2005.10399796
    Return to citation in text: [1]
  9. Song, Y.; Wang, J.; Teng, S. F.; Kesuma, D.; Deng, Y.; Duan, J.; Wang, J. H.; Qi, R. J.; Sim, M. M. Bioorg. Med. Chem. Lett. 2002, 12, 1129–1132. doi:10.1016/S0960-894X(02)00094-X
    Return to citation in text: [1]
  10. Schott, Y.; Decker, M.; Rommelspacher, H.; Lehmann, J. Bioorg. Med. Chem. Lett. 2006, 16, 5840–5843. doi:10.1016/j.bmcl.2006.08.067
    Return to citation in text: [1]
  11. Chen, Z.; Hu, G.; Li, D.; Chen, J.; Li, Y.; Zhou, H.; Xie, Y. Bioorg. Med. Chem. 2009, 17, 2351–2359. doi:10.1016/j.bmc.2009.02.015
    Return to citation in text: [1]
  12. Wang, W.; Nam, S.-J.; Lee, B.-C.; Kang, H. J. Nat. Prod. 2008, 71, 163–166. doi:10.1021/np070064o
    Return to citation in text: [1]
  13. Panarese, J. D.; Waters, S. P. Org. Biomol. Chem. 2013, 11, 3428–3431. doi:10.1039/c3ob40661j
    Return to citation in text: [1]
  14. Trieu, T. H.; Dong, J.; Zhang, Q.; Zheng, B.; Meng, T.-Z.; Lu, X.; Shi, X.-X. Eur. J. Org. Chem. 2013, 3271–3277. doi:10.1002/ejoc.201300080
    Return to citation in text: [1]
  15. García, M. D.; Wilson, J. A.; Emmerson, D. P. G.; Jenkins, P. R. Chem. Commun. 2006, 2586–2588. doi:10.1039/B604922B
    Return to citation in text: [1]
  16. García, M. D.; Wilson, J. A.; Emmerson, D. P. G.; Jenkins, P. R.; Mahale, S.; Chaudhuri, B. Org. Biomol. Chem. 2006, 4, 4478–4484. doi:10.1039/B613861F
    Return to citation in text: [1]
  17. Kennedy, J. P.; Breininger, M. L.; Lindsley, C. W. Tetrahedron Lett. 2009, 50, 7067–7069. doi:10.1016/j.tetlet.2009.09.180
    Return to citation in text: [1]
  18. Jin, H.; Zhang, P.; Bijian, K.; Ren, S.; Wan, S.; Alaoui-Jamali, M. A.; Jiang, T. Mar. Drugs 2013, 11, 1427–1439. doi:10.3390/md11051427
    Return to citation in text: [1]
  19. Meruva, S. B.; Raghunadh, A.; Kumar, N. A.; Vasudev, R.; Kumar, U. K. S.; Dev, R. V.; Dubey, P. K. J. Heterocycl. Chem. 2011, 48, 540–548. doi:10.1002/jhet.590
    Return to citation in text: [1]
  20. Wagh, M. B.; Shankar, R.; Kumar, U. K. S. Synlett 2011, 84–88. doi:10.1055/s-0030-1259098
    Return to citation in text: [1]
  21. Shankar, R.; Wagh, M. B.; Madhubabu, M. V.; Vembu, N.; Kumar, U. K. S. Synlett 2011, 844–848. doi:10.1055/s-0030-1259921
    Return to citation in text: [1]
  22. Wagh, M. B.; Shankar, R.; Mini, K.; Krishnamohan, T.; Madhubabu, M. V.; Pal, K. A.; Jayaprakash, S.; Krishna, T.; Dahanukar, V.; Kumar, U. K. S.; Gill, C. H. J. Heterocycl. Chem. 2013, 50, 49–55. doi:10.1002/jhet.991
    Return to citation in text: [1]
  23. Raghunadh, A.; Meruva, S. B.; Kumar, N. K.; Kumar, G. S.; Rao, L. V.; Kumar, U. K. S. Synthesis 2012, 283–289. doi:10.1055/s-0031-1289647
    Return to citation in text: [1]
  24. Shanmugapriya, D.; Shankar, R.; Satyanarayana, G.; Dahanukar, V. H.; Kumar, U. K. S.; Vembu, N. Synlett 2008, 2945–2950. doi:10.1055/s-0028-1087353
    Return to citation in text: [1] [2]
  25. Klingenberg, J. Org. Synth., Coll. Vol. IV 1963, 110.
    Return to citation in text: [1]
  26. Bigelow, L. A.; Hanslick, R. S. Org. Synth., Coll. Vol. II 1943, 244.
    Return to citation in text: [1]
  27. Shankar, R.; More, S. S.; Madhubabu, M. V.; Vembu, N.; Kumar, U. K. S. Synlett 2012, 1013–1020. doi:10.1055/s-0031-1290655
    Return to citation in text: [1] [2]
  28. The authors are thankful to referees for the useful suggestions.
    Return to citation in text: [1]
Other Beilstein-Institut Open Science Activities